Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips WiMi Hologram Cloud (NASDAQ: WIMI ) stock is on the move Wednesday following the release of its WiMi HoloAR lens. Source: Shutterstock The WiMi HoloAR lens is a new augmented reality (AR) device from the comp...
Gainers: Kadmon KDMN +73%, ICU Medical ICUI +32%, Candel Therapeutics CADL +17%, Gain Therapeutics GANX +9%, Concord Medical Services (NYSE:CCM) +9%. Losers: INmune Bio (NASDAQ:INMB) -22%, Inozyme Pharma (NASDAQ:INZY) -19%, Alector A...
Are These Top Biotech Stocks Worth Buying This Week? When considering which stocks to invest in amidst current stock market conditions, most would look towards the health care sector. Among biotech stocks, one subsection, in particular, continues to make headlines. That is t...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Kadmon Holdings (NASDAQ: KDMN ) stock is rising higher on Wednesday following news of a deal with Sanofi (NASDAQ: SNY ). Source: Shutterstock.com The big news pushing KDMN stock higher today is Sanofi a...
Barely a month after acquiring Translate Bio for its mRNA pipeline, French pharmaceutical giant Sanofi (NASDAQ: SNY) is at it again with a buyout of Kadmon Holdings (NASDAQ: KDMN) . Ahead of the opening bell Wednesday morning, Sanofi and Kadmon announced the two comp...
Read the full story here: For further details see: Wall Street Breakfast: Crypto Currencies Crater (Podcast)
Kadmon Holdings (NASDAQ:KDMN) +74% Sanofi strengthens transplant business with acquisition of Kadmon for $1.9B Gain Therapeutics (NASDAQ:GANX) +27% on positive GT-02287and GT-02329 data in Parkinson’s disease Alset EHome International (NASDAQ:AEI) +15% inv...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! We’re kicking off the day with an overview of the biggest pre-market stock movers for Wednesday! Source: Eric Urquhart/Shutterstock.com There’s plenty of reasons for stocks to be ...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Crypto crumbleCryptocurrencies and related stocks are facing less volatility this morning following Tuesday's plunge, which came as Bitcoin became legal te...
Adds Rezurock™ (belumosudil) an FDA-approved, first-in-class treatment for adult and pediatric patients 12 years and older with chronic graft-versus-host disease (cGVHD) after failure of at least two prior lines of systemic therapy PARIS, FRANCE and NEW YORK, NY / ACCESSWIRE / Sep...
News, Short Squeeze, Breakout and More Instantly...
Kadmon Holdings Inc. Company Name:
KDMN Stock Symbol:
NYSE Market:
- REZUROCK™ (belumosudil) 200 mg once daily (QD) tablets are now commercially available for shipment to prescribed patients in the United States - - Execution of strategic launch strategy underway; Third quarter REZUROCK net sales $12.2 million - - Sanofi acquisition of Kadm...
NEW YORK, NY / ACCESSWIRE / October 1, 2021 / Kadmon Holdings, Inc. (NASDAQ:KDMN) today announced it will present data from the ongoing Phase 1 clinical trial of KD033, its anti-PD-L1/IL-15 fusion protein, in patients with metastatic or locally advanced solid tumors, in addition to other IL-...
FinancialBuzz.com’s latest The Buzz Show: Featuring Our Corporate News Recap on “Kadmon Holdings, Inc. Skyrockets Amid Entering Definitive Merger Agreement with Sanofi Kadmon Holdings, Inc. (NASDAQ: KDMN) surged 73% in premarket trading after entering...